PHG

Koninklijke Philips NV

Price

$29.09

return (12m)

p/e

22.75

p/bv

1.95

DIVIDEND YIELD

3.75%

PHG price

Koninklijke Philips

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PHG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals PHG

Valuation

P/E

22.75

Sector -2.34

Industry 11.10

P/BV

1.95

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.25

Sector 2.00

Industry 1.71

EV/EBITDA

49.33

Sector -23.69

Industry -398.52

EV/EBIT

97.20

Sector -36.60

Industry -80.73

P/EBITDA

8.25

Sector -0.10

Industry 8.30

P/EBIT

14.11

Sector -2.08

Industry 5.69

P/Total Assets

0.82

Sector 1.18

Industry 1.57

P/Net Current Assets

-3.67

Sector -10.91

Industry -3.38

P/Working Capital

9.45

Sector 0.09

Industry 10.51

EPS

1.19

Sector -0.93

Industry 1.10

BVPS

13.87

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

45.20%

Sector 44.28%

Industry 29.23%

EBITDA Margin

13.78%

Sector -291.45%

Industry 4.29%

EBIT Margin

6.99%

Sector -195.44%

Industry 1.44%

Operating Margin

8.72%

Sector -25.72%

Industry 2.16%

Net Profit Margins

5.50%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.14

Sector 0.12

Industry 0.27

Profitability

ROE

8.56%

Sector -34.71%

Industry 6.97%

ROA

3.58%

Sector -28.76%

Industry 2.97%

ROIC

3.53%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

3.75%

Sector -

Industry 0.01%

Payout

85.31%

Sector -

Industry 0.54%

Debt

Current Ratio

1.32

Sector 1.87

Industry 1.51

Net Debt / EBITDA

7.99

Sector -2.18

Industry -1.68

Net Debt / EBIT

15.75

Sector -0.74

Industry -7.00

Net Debt / Equity

0.38

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.60

Sector -0.64

Industry 0.35

Equity/Assets

0.42

Sector 0.43

Industry 0.46

Liabilities/Assets

0.58

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

0.40%

Sector -

Industry -

5Y Earnings CAGR

-21.96%

Sector -

Industry -

FAIR VALUE OF Koninklijke Philips ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$29.09

Fair Value

$19.27

Upside Return potential.

-33.74%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PHG

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PHG Koninklijke Philips NV	$29.09	33.58%	3.75%	22.75	1.95	8.56%	5.50%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PHG Historical Dividends

current DY: 3.75%

5-year average DY: 2.68%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/13/2026	06/03/2026	1.01300000
Dividends	05/13/2025	06/06/2025	0.88600000
Dividends	05/13/2022	06/08/2022	0.96410000
Dividends	05/11/2021	06/09/2021	1.03310000
Dividends	05/06/2020	06/04/2020	0.93560000
Dividends	05/14/2019	06/13/2019	0.96120000
Dividends	05/08/2018	06/06/2018	0.99200000
Dividends	05/16/2017	06/14/2017	0.86300000
Dividends	05/17/2016	06/15/2016	0.88010000
Dividends	05/12/2015	06/10/2015	0.90900000
Dividends	05/07/2014	06/04/2014	1.09800000
Dividends	05/09/2013	06/05/2013	0.98200000
Dividends	05/04/2012	05/31/2012	0.99800000
Dividends	04/06/2011	05/04/2011	1.01700000
Dividends	03/31/2010	04/28/2010	0.95100000
Dividends	04/01/2009	04/07/2009	0.90000000
Dividends	04/01/2008	04/07/2008	1.02100000
Dividends	04/03/2007	04/10/2007	0.78140000
Dividends	04/04/2006	04/10/2006	0.53700000
Dividends	04/05/2005	04/11/2005	0.52100000
Dividends	03/30/2004	04/05/2004	0.44200000
Dividends	04/01/2003	04/07/2003	0.38030000
Dividends	04/04/2002	04/08/2002	0.30930000
Dividends	04/03/2001	04/18/2001	0.32300000

ABOUT Koninklijke Philips

Koninklijke Philips NV

Average Investor10 user rating

4.0 (0 people)

States of America

135 years

Founded: 1891

1987

Time since IPO - 39 years

78.189

Employees

Koninklijke Philips NV (States of America) is listed on the NYSE and has a market capitalization of $25.71 billion, with shareholders equity totaling $13.20 billion.

The company employs approximately 78.189 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Koninklijke Philips NV reported $20.54 billion in revenue, generating net income of $1.13 billion.

Key financial metrics include a P/E ratio of 22.75, a price-to-book (P/B) ratio of 1.95, and a trailing twelve-month dividend yield of 3.75%.

The company trades under the ticker PHG.

Market cap

$25.71 billion

Net worth

$13.20 billion

$13,200,000,000.00

Assets

$31.52 billion

$31,521,390,000.00

Total Shares Outstanding

952.00 million

952,000,000

Average Daily Trading Volume

$1.15 million

$1,148,812.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

PHG

revenue by Business Segment Koninklijke Philips

PHG revenue and profits

Financial Results PHG

DRAG THE FRAME TO SEE MORE DATA

PHG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56